Rep. Colin Peterson (D-MN), chairman of the House Agriculture Committee, introduced legislation (H.R. 5587) to include hemp-derived CBD in the definition of dietary supplements under the Federal Food, Drug and Cosmetic Act (FD&C Act). The bill would also require a study and report from the U.S. Department of Agriculture, which oversees the production of hemp, on the regulatory and market barriers for farmers engaged in hemp production.

House Agriculture Committee Chairman Collin Peterson of Minnesota introduced legislation today that would provide the Food and Drug Administration with the flexibility to allow hemp-derived cannabidiol (CBD) to be marketed in dietary supplements. The bill would also require a study and report from the U.S. Department of Agriculture, which oversees the production of hemp, on the regulatory and market barriers for farmers engaged in hemp production.

“The last two Farm Bills were landmark successes for hemp, but we are still very early in this process, and growers need regulatory certainty,” said Peterson. “This bill will allow FDA to regulate CBD that comes from hemp as a dietary supplement, providing a pathway forward for hemp-derived products. It would also identify barriers to success for hemp farmers, informing growers and policy makers of the challenges facing this new industry.”

READ THE BILL ...

Media Coverage: